Prostate Cancer Drug About To Confront Insurers With Sovaldi-Size Problem |
| June 06, 2017 | June 2017 Bond Updates |
|
Abiraterone shows dramatic effects on survival in patients with metastatic prostate cancer. Can we afford it? Who is going to pay? |
| View more at: http://www.forbes.com/sites/benjamindavies/2017/06/05/prostate-cancer-drug-about-to-confront-insurers-with-sovaldi-size-problem/ |
| Related News |